Citius Oncology, Inc. (CTOR)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Leonard L. Mazur | Chairman, CEO & President | -- | -- | 1945 |
Mr. Jaime Bartushak | CFO & Treasurer | -- | -- | 1968 |
Dr. Myron S. Czuczman M.D. | Chief Medical Officer | -- | -- | 1960 |
Mr. Myron Z. Holubiak | Secretary & Director | -- | -- | 1947 |
Citius Oncology, Inc.
- Sector:?
- Healthcare
- Industry:? Drug Manufacturers - Specialty & Generic
Description
Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York.Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
July 19, 2024 at 12:00 AM UTC
425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
July 11, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
June 18, 2024 at 12:00 AM UTC
425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions